Fuse Medical Valuation

FZMD Stock  USD 0.12  0.07  140.00%   
Fuse Medical seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Fuse Medical from reviewing the firm fundamentals such as Operating Margin of (0.05) %, shares owned by insiders of 88.44 %, and Shares Outstanding of 72.9 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
0.12
Please note that Fuse Medical's price fluctuation is out of control at this time. Calculation of the real value of Fuse Medical is based on 3 months time horizon. Increasing Fuse Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Fuse pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Fuse Medical. Since Fuse Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fuse Pink Sheet. However, Fuse Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.12 Real  0.0798 Hype  0.12 Naive  0.14
The real value of Fuse Pink Sheet, also known as its intrinsic value, is the underlying worth of Fuse Medical Company, which is reflected in its stock price. It is based on Fuse Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Fuse Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.08
Real Value
43.10
Upside
Estimating the potential upside or downside of Fuse Medical helps investors to forecast how Fuse pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fuse Medical more accurately as focusing exclusively on Fuse Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.060.11
Details
Hype
Prediction
LowEstimatedHigh
0.010.1243.14
Details
Naive
Forecast
LowNext ValueHigh
00.1443.16
Details

Fuse Medical Total Value Analysis

Fuse Medical is currently expected to have valuation of 12.09 M with market capitalization of 9.84 M, debt of 200 K, and cash on hands of 604 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Fuse Medical fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
12.09 M
9.84 M
200 K
604 K

Fuse Medical Investor Information

About 88.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. Fuse Medical had not issued any dividends in recent years. The entity had 68:1000 split on the 30th of May 2014. Fuse Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Fuse Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fuse Medical has an asset utilization ratio of 111.53 percent. This indicates that the Company is making $1.12 for each dollar of assets. An increasing asset utilization means that Fuse Medical is more efficient with each dollar of assets it utilizes for everyday operations.

Fuse Medical Ownership Allocation

Fuse Medical holds a total of 72.9 Million outstanding shares. Fuse Medical shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.44 percent of Fuse Medical outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Fuse Medical Profitability Analysis

The company reported the previous year's revenue of 20.41 M. Net Loss for the year was (1.59 M) with profit before overhead, payroll, taxes, and interest of 11.94 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Fuse Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Fuse Medical and how it compares across the competition.

About Fuse Medical Valuation

The pink sheet valuation mechanism determines Fuse Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Fuse Medical. We calculate exposure to Fuse Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fuse Medical's related companies.
Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange.

8 Steps to conduct Fuse Medical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Fuse Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Fuse Medical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Fuse Medical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Fuse Medical's revenue streams: Identify Fuse Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Fuse Medical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Fuse Medical's growth potential: Evaluate Fuse Medical's management, business model, and growth potential.
  • Determine Fuse Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Fuse Medical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Fuse Medical Growth Indicators

Investing in growth stocks can be very risky. If the company such as Fuse Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding70.2 M
Quarterly Earnings Growth Y O Y-0.716
Retained Earnings-5.6 M

Complementary Tools for Fuse Pink Sheet analysis

When running Fuse Medical's price analysis, check to measure Fuse Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fuse Medical is operating at the current time. Most of Fuse Medical's value examination focuses on studying past and present price action to predict the probability of Fuse Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fuse Medical's price. Additionally, you may evaluate how the addition of Fuse Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity